Pharmaceutical Information |
Drug Name |
Guanidine |
Drug ID |
BADD_D01048 |
Description |
A strong organic base existing primarily as guanidium ions at physiological pH. It is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. (From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed) It is also used in the treatment of myasthenia and as a fluorescent probe in HPLC. |
Indications and Usage |
For the reduction of the symptoms of muscle weakness and easy fatigability associated with the myasthenic syndrome of Eaton-Lambert. It is not indicated for treating myasthenia gravis. |
Marketing Status |
approved |
ATC Code |
Not Available |
DrugBank ID |
DB00536
|
KEGG ID |
D11626
|
MeSH ID |
D019791
|
PubChem ID |
3520
|
TTD Drug ID |
D0F7NZ
|
NDC Product Code |
Not Available |
UNII |
JU58VJ6Y3B
|
Synonyms |
Guanidine | Guanidinium | Guanidine Monohydrate | Monohydrate, Guanidine | Guanidine Monohydrobromide | Monohydrobromide, Guanidine | Guanidine Monohydroiodine | Monohydroiodine, Guanidine | Guanidine Sulfite (1:1) | Guanidine Phosphate | Phosphate, Guanidine | Guanidine Sulfate | Sulfate, Guanidine | Guanidine Sulfate (1:1) | Guanidine Sulfate (2:1) | Guanidine Hydrochloride | Hydrochloride, Guanidine | Guanidinium Chloride | Chloride, Guanidinium | Guanidium Chloride | Chloride, Guanidium | Guanidine Monohydrochloride | Monohydrochloride, Guanidine | Guanidine Nitrate | Nitrate, Guanidine |
|
Chemical Information |
Molecular Formula |
CH5N3 |
CAS Registry Number |
113-00-8 |
SMILES |
C(=N)(N)N |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|